Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 49 Rectal Neoplasms 32 Pancreatic Neoplasms 28 Colonic Neoplasms 24 Stomach Neoplasms 19 Neoplasm Metastasis 15 Neoplasms 13 Esophageal Neoplasms 10 Breast Neoplasms 7 Head and Neck Neoplasms 6 Recurrence 5 Lung Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Adenocarcinoma Of Esophagus 5 Lymphoma, Large B-Cell, Diffuse 4 Carcinoma, Hepatocellular 4 Ovarian Neoplasms 3 Lymphoma, Extranodal NK-T-Cell 3 Liver Neoplasms 3 Gastrointestinal Neoplasms 3 Gallbladder Neoplasms 3 Fallopian Tube Neoplasms 3 Cholangiocarcinoma 3 Adenocarcinoma 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Peritoneal Neoplasms 2 Myelodysplastic Syndromes 2 Melanoma 2 Lymphoma, Non-Hodgkin 2

Interventions

Panitumumab 1 Oxaliplatin 1 Epirubicin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Oesophago-gastric Cancer × Oxaliplatin × Clear all

NCT00824785 2012-12-11

REAL3

Royal Marsden NHS Foundation Trust

Phase 3 Terminated

Gastrointestinal

Oesophago-gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡